Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2020-000147-31Phase 2Active
Phase 2 trial of ascorbic acid in burn injury, sponsored by Clinical Evaluation Research Unit. Primary endpoint: Feasibility metrics including compliance with the study protocol. Started Sep 2022; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2020-000147-31.